An in-depth look to SCI PHARMTECH INC operating, investing, and financing activities

4119 free cash flow for Q3 24 is -157.5 M TWD. For 2023, 4119 free cash flow was -813.59 M TWD and operating cash flow was 215.77 M TWD.